The use of prostate-specific membrane antigen (PSMA)-directed applications in modern
prostate cancer management has evolved rapidly over the past few years, hel** to …

Radiotherapy and radiation oncology play a key role in the clinical management of patients
suffering from oncological diseases. In clinical routine, anatomic imaging such as contrast …

Background Prostate-specific membrane antigen (PSMA) PET is highly sensitive in
identifying disease recurrence in men with biochemical recurrence of prostate cancer (BCR) …

Prostate cancer (PCa) is one of the most frequently diagnosed malignancies of men in the
world. Due to a variety of treatment options in different risk groups, proper diagnostic and …

18F-DCFPyL (2-(3-{1-carboxy-5-[(6-18F-fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-
pentanedioic acid), a prostate-specific membrane antigen–targeting radiotracer, has shown …

Background Salvage radiotherapy (SRT) for prostate cancer (PCa) recurrence after
prostatectomy offers long-term biochemical control in about 50–60% of patients. SRT is …

68Ga-prostate-specific membrane antigen (68Ga-PSMA) PET/CT is a commonly used
imaging modality in prostate cancers. However, few studies have compared the diagnostic …

Background and purpose Focal therapies are a promising approach to treat prostate cancer
(PCa) more precisely instead of conventional whole gland treatment. Nowadays …

Abstract Introduction Primary prostate cancer (PCa) can be visualized on prostate-specific
membrane antigen positron emission tomography (PSMA-PET) with high accuracy …

Importance Although prostate-specific membrane antigen positron emission tomography
(PSMA-PET) has shown improved sensitivity and specificity compared with conventional …